The European Union (EU) has decided to suspend its exports due to a shortage of the vaccine. However, the decision was withdrawn after strong international criticism.
The European Union (EU) has said in response to a lack of availability of the AstraZeneca vaccine in its countries that exports of the vaccine to Northern Ireland will be restricted so that the first vaccine can be given to its own people. The EU’s stance has caused a stir in Britain and Ireland, with governments calling such a move a violation of the recently concluded Bridgett Accords.
The World Health Organization (WHO) has also openly criticized the European Union, saying “nationalist” tendencies over vaccine availability are “disturbing”. According to the WHO, the Corona epidemic is a global challenge and countries need to think beyond their borders to meet it.
Such a ban by the European Union could affect the availability of the vaccine in hundreds of countries, including the United Kingdom, the United States, Canada and Australia.
According to EU officials, the purpose of restricting vaccine exports was to protect the health of citizens of member countries, which is its top priority.
However, in a statement, the European bloc’s health commissioner, Stella Kyriakides, said that they are not trying to protect ourselves from any particular country, nor are they competing with any other country.
The European Union (EU) has said in a statement that the proposed reduction in vaccine exports was “temporary” and was not intended to curb exports.
Under EU rules and regulations, the authorities have the power to suspend vaccine exports from a pharmaceutical company on the grounds that it has not fulfilled its agreements with member states.
AstraZeneca is a British and Swedish company that developed the ‘Oxford’ vaccine to prevent corona.
The European Union (EU) has been at loggerheads with the company over not providing as many vaccines as it had promised.